BERLDRGPharmaceuticals
Beryl Drugs Ltd — Balance Sheet
₹19.28
-9.36%
Beryl Drugs Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.51 Cr | 0.51 Cr | 0.51 Cr | 0.51 Cr | — |
| Share Issued | 0.51 Cr | 0.51 Cr | 0.51 Cr | 0.51 Cr | — |
| Net Debt | 3.26 Cr | 4.97 Cr | 4.26 Cr | 5.02 Cr | — |
| Total Debt | 4.07 Cr | 5.09 Cr | 4.54 Cr | 5.29 Cr | — |
| Tangible Book Value | 9.50 Cr | 8.92 Cr | 8.07 Cr | 7.29 Cr | — |
| Invested Capital | 13.58 Cr | 14.02 Cr | 12.61 Cr | 12.59 Cr | — |
| Working Capital | 4.74 Cr | 4.47 Cr | 4.05 Cr | 2.04 Cr | — |
| Net Tangible Assets | 9.50 Cr | 8.92 Cr | 8.07 Cr | 7.29 Cr | — |
| Common Stock Equity | 9.50 Cr | 8.92 Cr | 8.07 Cr | 7.29 Cr | — |
| Total Capitalization | 11.24 Cr | 11.33 Cr | 10.77 Cr | 8.97 Cr | — |
| Total Equity Gross Minority Interest | 9.50 Cr | 8.92 Cr | 8.07 Cr | 7.29 Cr | — |
| Stockholders Equity | 9.50 Cr | 8.92 Cr | 8.07 Cr | 7.29 Cr | — |
| Other Equity Interest | 4.41 Cr | 3.83 Cr | 2.97 Cr | 2.20 Cr | — |
| Capital Stock | 5.09 Cr | 5.09 Cr | 5.09 Cr | 5.09 Cr | — |
| Common Stock | 5.09 Cr | 5.09 Cr | 5.09 Cr | 5.09 Cr | — |
| Total Liabilities Net Minority Interest | 6.46 Cr | 8.56 Cr | 9.45 Cr | 10.53 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.16 Cr | 2.81 Cr | 3.10 Cr | 2.04 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.74 Cr | 2.40 Cr | 2.71 Cr | 1.68 Cr | — |
| Long Term Debt | 1.74 Cr | 2.40 Cr | 2.71 Cr | 1.68 Cr | — |
| Long Term Provisions | 0.42 Cr | 0.40 Cr | 0.40 Cr | 0.36 Cr | — |
| Current Liabilities | 4.30 Cr | 5.76 Cr | 6.34 Cr | 8.49 Cr | — |
| Other Current Liabilities | 0.38 Cr | 0.56 Cr | 0.73 Cr | -2000.00 | — |
| Current Debt And Capital Lease Obligation | 2.34 Cr | 2.69 Cr | 1.84 Cr | 3.62 Cr | — |
| Current Debt | 2.34 Cr | 2.69 Cr | 1.84 Cr | 3.62 Cr | — |
| Current Provisions | 0.12 Cr | 0.06 Cr | 0.04 Cr | 0.02 Cr | — |
| Payables | 1.24 Cr | 2.45 Cr | 3.76 Cr | 3.39 Cr | — |
| Total Tax Payable | 0.12 Cr | 0.15 Cr | 0.12 Cr | 0.04 Cr | — |
| Accounts Payable | 1.12 Cr | 2.02 Cr | 3.25 Cr | 3.06 Cr | — |
| Total Assets | 15.96 Cr | 17.49 Cr | 17.51 Cr | 17.82 Cr | — |
| Total Non Current Assets | 6.92 Cr | 7.27 Cr | 7.12 Cr | 7.29 Cr | — |
| Other Non Current Assets | 0.47 Cr | -2000.00 | 5000.00 | 1000.00 | — |
| Non Current Deferred Taxes Assets | 61000.00 | 0.10 Cr | 0.13 Cr | 0.19 Cr | — |
| Investmentin Financial Assets | 0.24 Cr | 0.00 | 0.15 Cr | 0.16 Cr | — |
| Available For Sale Securities | 0.24 Cr | 0.22 Cr | 0.15 Cr | 0.16 Cr | — |
| Investment Properties | 0.20 Cr | 0.20 Cr | 0.21 Cr | 0.18 Cr | — |
| Goodwill And Other Intangible Assets | 7000.00 | 12000.00 | 9000.00 | 21000.00 | — |
| Other Intangible Assets | 7000.00 | 12000.00 | 9000.00 | 21000.00 | — |
| Net PPE | 6.00 Cr | 5.96 Cr | 5.81 Cr | 5.86 Cr | — |
| Current Assets | 9.04 Cr | 10.22 Cr | 10.39 Cr | 10.53 Cr | — |
| Other Current Assets | 0.74 Cr | 0.04 Cr | 0.08 Cr | 0.07 Cr | — |
| Assets Held For Sale Current | 0.00 | 0.00 | 0.00 | 0.05 Cr | — |
| Inventory | 1.90 Cr | 1.26 Cr | 1.05 Cr | 2.98 Cr | — |
| Taxes Receivable | 0.00 | 0.09 Cr | 0.55 Cr | 0.82 Cr | — |
| Accounts Receivable | 5.46 Cr | 7.58 Cr | 6.90 Cr | 4.45 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.94 Cr | 0.22 Cr | 0.57 Cr | 0.67 Cr | — |
| Other Short Term Investments | 0.13 Cr | 0.10 Cr | 0.29 Cr | 0.40 Cr | — |
| Cash And Cash Equivalents | 0.81 Cr | 0.13 Cr | 0.28 Cr | 0.27 Cr | — |
| Retained Earnings | — | 3.77 Cr | 3.00 Cr | 2.23 Cr | 2.89 Cr |
| Other Non Current Liabilities | — | -7000.00 | -1000.00 | -1000.00 | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 0.40 Cr | 0.40 Cr | 0.36 Cr | 0.31 Cr |
| Current Deferred Taxes Liabilities | — | 0.04 Cr | 0.04 Cr | 0.04 Cr | 0.04 Cr |
| Other Payable | — | 0.28 Cr | 0.39 Cr | 0.29 Cr | 1.32 Cr |
| Non Current Prepaid Assets | — | 1.00 Cr | 0.82 Cr | 0.90 Cr | 0.85 Cr |
| Accumulated Depreciation | — | -5.67 Cr | -4.61 Cr | -3.81 Cr | -2.75 Cr |
| Gross PPE | — | 11.63 Cr | 10.43 Cr | 9.67 Cr | 10.07 Cr |
| Construction In Progress | — | 0.06 Cr | 0.06 Cr | 0.06 Cr | 0.06 Cr |
| Other Properties | — | 0.65 Cr | 0.64 Cr | 0.64 Cr | 0.59 Cr |
| Machinery Furniture Equipment | — | 8.27 Cr | 7.43 Cr | 6.61 Cr | 7.01 Cr |
| Buildings And Improvements | — | 2.39 Cr | 2.05 Cr | 2.11 Cr | 2.16 Cr |
| Land And Improvements | — | 0.25 Cr | 0.25 Cr | 0.25 Cr | 0.25 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 1.02 Cr | 1.21 Cr | 0.68 Cr | 0.62 Cr |
| Other Inventories | — | 46000.00 | 0.02 Cr | 0.25 Cr | — |
| Finished Goods | — | 0.66 Cr | 0.49 Cr | 0.81 Cr | 0.50 Cr |
| Raw Materials | — | 0.60 Cr | 0.54 Cr | 1.92 Cr | 1.77 Cr |
| Other Receivables | — | 1000.00 | 0.02 Cr | 0.81 Cr | 0.82 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.59 Cr | -0.39 Cr | -0.33 Cr | -0.13 Cr |
| Gross Accounts Receivable | — | 8.17 Cr | 7.29 Cr | 4.78 Cr | 4.67 Cr |
| Cash Financial | — | 0.13 Cr | 0.28 Cr | 0.27 Cr | 0.45 Cr |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 0.21 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Beryl Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.